365 related articles for article (PubMed ID: 10830910)
21. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER
Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293
[TBL] [Abstract][Full Text] [Related]
22. [Large germline deletion of the VHL gene in Chinese families with von Hippel-Lindau syndrome].
Zhang J; Chen HG; Xue W; Zhou LX; Huang YR
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Oct; 26(5):539-41. PubMed ID: 19806577
[TBL] [Abstract][Full Text] [Related]
23. Genotype-phenotype correlation in von Hippel-Lindau families with renal lesions.
Gallou C; Chauveau D; Richard S; Joly D; Giraud S; Olschwang S; Martin N; Saquet C; Chrétien Y; Méjean A; Correas JM; Benoît G; Colombeau P; Grünfeld JP; Junien C; Béroud C
Hum Mutat; 2004 Sep; 24(3):215-24. PubMed ID: 15300849
[TBL] [Abstract][Full Text] [Related]
24. Genotype-phenotype analysis of von Hippel-Lindau syndrome in Korean families: HIF-α binding site missense mutations elevate age-specific risk for CNS hemangioblastoma.
Lee JS; Lee JH; Lee KE; Kim JH; Hong JM; Ra EK; Seo SH; Lee SJ; Kim MJ; Park SS; Seong MW
BMC Med Genet; 2016 Jul; 17(1):48. PubMed ID: 27439424
[TBL] [Abstract][Full Text] [Related]
25. Role of VHL gene mutation in human cancer.
Kim WY; Kaelin WG
J Clin Oncol; 2004 Dec; 22(24):4991-5004. PubMed ID: 15611513
[TBL] [Abstract][Full Text] [Related]
26. von Hippel-Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel-Lindau disease.
Vortmeyer AO; Gnarra JR; Emmert-Buck MR; Katz D; Linehan WM; Oldfield EH; Zhuang Z
Hum Pathol; 1997 May; 28(5):540-3. PubMed ID: 9158701
[TBL] [Abstract][Full Text] [Related]
27. Genotype-phenotype correlation in von Hippel-Lindau disease: identification of a mutation associated with VHL type 2A.
Chen F; Slife L; Kishida T; Mulvihill J; Tisherman SE; Zbar B
J Med Genet; 1996 Aug; 33(8):716-7. PubMed ID: 8863170
[TBL] [Abstract][Full Text] [Related]
28. von Hippel-Lindau disease.
Couch V; Lindor NM; Karnes PS; Michels VV
Mayo Clin Proc; 2000 Mar; 75(3):265-72. PubMed ID: 10725953
[TBL] [Abstract][Full Text] [Related]
29. Von Hippel-Lindau gene alterations in sporadic benign and malignant pheochromocytomas.
Dannenberg H; De Krijger RR; van der Harst E; Abbou M; IJzendoorn Y; Komminoth P; Dinjens WN
Int J Cancer; 2003 Jun; 105(2):190-5. PubMed ID: 12673678
[TBL] [Abstract][Full Text] [Related]
30. Molecular characterization and ophthalmic investigation of a large family with type 2A Von Hippel-Lindau Disease.
Allen RC; Webster AR; Sui R; Brown J; Taylor CM; Stone EM
Arch Ophthalmol; 2001 Nov; 119(11):1659-65. PubMed ID: 11709017
[TBL] [Abstract][Full Text] [Related]
31. Molecularly genetic analysis of von Hippel-Lindau associated central nervous system hemangioblastoma.
Zhou J; Wang J; Li N; Zhang X; Zhou H; Zhang R; Ma H; Zhou X
Pathol Int; 2010 Jun; 60(6):452-8. PubMed ID: 20518900
[TBL] [Abstract][Full Text] [Related]
32. Third International Meeting on von Hippel-Lindau disease.
Zbar B; Kaelin W; Maher E; Richard S
Cancer Res; 1999 May; 59(9):2251-3. PubMed ID: 10232616
[TBL] [Abstract][Full Text] [Related]
33. Solid renal tumor severity in von Hippel Lindau disease is related to germline deletion length and location.
Maranchie JK; Afonso A; Albert PS; Kalyandrug S; Phillips JL; Zhou S; Peterson J; Ghadimi BM; Hurley K; Riss J; Vasselli JR; Ried T; Zbar B; Choyke P; Walther MM; Klausner RD; Linehan WM
Hum Mutat; 2004 Jan; 23(1):40-6. PubMed ID: 14695531
[TBL] [Abstract][Full Text] [Related]
34. The von Hippel-Lindau (VHL) germline mutation V84L manifests as early-onset bilateral pheochromocytoma.
Abbott MA; Nathanson KL; Nightingale S; Maher ER; Greenstein RM
Am J Med Genet A; 2006 Apr; 140(7):685-90. PubMed ID: 16502427
[TBL] [Abstract][Full Text] [Related]
35. Genetic characterization and structural analysis of VHL Spanish families to define genotype-phenotype correlations.
Ruiz-Llorente S; Bravo J; Cebrián A; Cascón A; Pollan M; Tellería D; Letón R; Urioste M; Rodríguez-López R; de Campos JM; Muñoz MJ; Lacambra C; Benítez J; Robledo M
Hum Mutat; 2004 Feb; 23(2):160-169. PubMed ID: 14722919
[TBL] [Abstract][Full Text] [Related]
36. A variety of phenotype with R161Q germline mutation of the von Hippel-Lindau tumor suppressor gene in Japanese kindred.
Iida K; Okimura Y; Takahashi K; Inomata S; Iguchi G; Kaji H; Chihara K
Int J Mol Med; 2004 Mar; 13(3):401-4. PubMed ID: 14767570
[TBL] [Abstract][Full Text] [Related]
37. Genetic study of a large Chinese kindred with von Hippel-Lindau disease.
Huang YR; Zhang J; Wang JD; Fan XD
Chin Med J (Engl); 2004 Apr; 117(4):552-7. PubMed ID: 15109448
[TBL] [Abstract][Full Text] [Related]
38. Retinal hemangioblastoma in von Hippel-Lindau disease: a clinical and molecular study.
Dollfus H; Massin P; Taupin P; Nemeth C; Amara S; Giraud S; Béroud C; Dureau P; Gaudric A; Landais P; Richard S
Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):3067-74. PubMed ID: 12202531
[TBL] [Abstract][Full Text] [Related]
39. Somatic mosaicism in von Hippel-Lindau Disease.
Murgia A; Martella M; Vinanzi C; Polli R; Perilongo G; Opocher G
Hum Mutat; 2000 Jan; 15(1):114. PubMed ID: 10612832
[TBL] [Abstract][Full Text] [Related]
40. In silico VHL Gene Mutation Analysis and Prognosis of Pancreatic Neuroendocrine Tumors in von Hippel-Lindau Disease.
Tirosh A; El Lakis M; Green P; Nockel P; Patel D; Nilubol N; Gara SK; Keutgen XM; Linehan WM; Kebebew E
J Clin Endocrinol Metab; 2018 Apr; 103(4):1631-1638. PubMed ID: 29294023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
